Products such as the CapitalBio Mycobacteria Identification Array Kit and CapitalBio Tuberculosis Drug-Resistance Detection Array Kit provide strong support for China's tuberculosis prevention and control. The CapitalBio Tuberculosis Rapid Molecular Diagnostics System was a core achievement of the National Science and Technology Major Projects of the National Health and Family Planning Commission (NHFPC) during the 11th Five-Year Plan period. The diagnostic system has been widely applied in the medical organizations in nearly 30 provinces, autonomous regions and municipalities.

Moreover, it has passed evaluation by the NHFPC-Bill & Melinda Gates Foundation's tuberculosis prevention and control project, and can provide an integrated rapid diagnostics solution for clinical tuberculosis prevention and control.

In 2009, the CapitalBio Mycobacteria Identification Array Kit was named a Beijing independent innovation product and one of the top 10 advanced reagents of the year in Chinese laboratory medicine.